New Covid vaccine effective against Omicron to be ready by March, says Pfizer CEO

Jan.11: A new vaccine targeting the Omicron variant of Covid-19 will be ready by March 2022, confirmed Pfizer CEO Albert Bourla on Monday. Bourla highlighted that the said vaccine will also target other variants that are currently circulating.  However, he also emphasised that it is still not clear whether or not the Omicron-targeted vaccine is currently needed and its future usage, yet the pharma company is instrumental in developing the doses since “some countries” want it ready shortly.

The Omicron variant, designated as a “variant of concern” by the World Health Organization, has been rampaging across the world, even amongst the vaccinated. Many are hopeful that the Omicron variant could also mean the beginning of the end of coronavirus.